| Alternative NSN: 6505-01-252-0802 |
| Item Name: Clorazepate Dipotassium Tablets |
| NIIN: 012520802 |
| NCB Code: USA (01) |
| Manufacturers: Abbott Laboratories Inc, Actavis Inc, Danbury Pharmacal Inc, Mylan Pharmaceuticals Inc, Rugby Group Inc, Schein Henry Inc, Taro Pharmaceuticals Usa Inc, Warner Lambert Ltd |
Browse NSN parts of NSN 6505-01-252-0802 and get lowest price for your requested parts in 15 minutes. Just ordered part of NSN 6505-01-252-0802 like 4389-53, NDC00047-0451-30, NDC00074-4389-53, NDC00228-3067-50, NDC00364-2201-05 described as Clorazepate Dipotassium Tablets from industry leading manufactures such as Abbott Laboratories Inc, Warner Lambert Ltd, Actavis Inc, Schein Henry Inc, Mylan Pharmaceuticals Inc. We are proud to offer an inventory of over 2 billion ready-to-ship parts, 24/7 availability, and key locations in the U.S./abroad. These attributes allow us to meet all aircraft on ground (AOG) requirements with ease.
| Part No | Manufacturer | Item Name | QTY | RFQ |
|---|---|---|---|---|
| 4389-53 | Abbott Laboratories Inc | clorazepate dipotassium tablets | Avl | RFQ |
| NDC00047-0451-30 | Warner Lambert Ltd | clorazepate dipotassium tablets | Avl | RFQ |
| NDC00074-4389-53 | Abbott Laboratories Inc | clorazepate dipotassium tablets | Avl | RFQ |
| NDC00228-3067-50 | Actavis Inc | clorazepate dipotassium tablets | Avl | RFQ |
| NDC00364-2201-05 | Schein Henry Inc | clorazepate dipotassium tablets | Avl | RFQ |
| NDC00378-0030-05 | Mylan Pharmaceuticals Inc | clorazepate dipotassium tablets | Avl | RFQ |
| NDC00536-4940-05 | Rugby Group Inc | clorazepate dipotassium tablets | Avl | RFQ |
| NDC00591-0363-05 | Danbury Pharmacal Inc | clorazepate dipotassium tablets | Avl | RFQ |
| NDC51672-4042-02 | Taro Pharmaceuticals Usa Inc | clorazepate dipotassium tablets | Avl | RFQ |
| MRC | Criteria | Characteristic |
|---|---|---|
| AJCN | PROTECTIVE STORAGE FEATURE | SECURITY STORAGE |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 3.750 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 500.000 TABLETS |
| FEAT | SPECIAL FEATURES | SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CLORAZEPATE DIPOTASSIUM TABLETS 3.75MG 500S BT |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
|
6505-00-004-6658 (6505000046658) |
6505-00-004-6666 (6505000046666) |
6505-00-004-6676 (6505000046676) |
|
6505-00-005-3940 (6505000053940) |
6505-00-006-3321 (6505000063321) |
6505-00-007-2156 (6505000072156) |
|
6505-00-007-4529 (6505000074529) |
6505-00-007-4531 (6505000074531) |
6505-00-007-4535 (6505000074535) |
|
6505-00-007-4538 (6505000074538) |
6505-00-007-8290 (6505000078290) |
6505-00-007-8293 (6505000078293) |
All Orders are Fulfilled in the U.S.A.
All shipments must comply with U.S.A export laws.
No exceptions.
The only independent distributor
with a NO CHINA SOURCING Pledge
“We Proudly Support Intrepid Fallen Heroes Fund that serves United States Military Personal experiencing the Invisible Wounds of War : Traumatic Brain Injury (TBI) and Post Traumatic Stress (PTS). Please visit website (www.fallenheroesfund.org) and help in their valiant effort”.
Before You Go, Why Don’t You Take a Look at Our Aviation Parts Catalog.
Request for Quote